These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 15666963

  • 1. A malignant neuroleptic spectrum: review of diagnostic criteria and treatment implications in three case reports.
    Pandya M, Pozuelo L.
    Int J Psychiatry Med; 2004; 34(3):277-85. PubMed ID: 15666963
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oral Asenapine overdose leading to Neuroleptic Malignant Syndrome (NMS).
    Das S, Purushothaman ST, Bc M, Chatterjee SS, Kartha A, Rajan V.
    Asian J Psychiatr; 2017 Dec; 30():31-32. PubMed ID: 28711682
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neuroleptic malignant syndrome and the acute phase response.
    Rosebush PI, Anglin RE, Richards C, Mazurek MF.
    J Clin Psychopharmacol; 2008 Aug; 28(4):459-61. PubMed ID: 18626278
    [No Abstract] [Full Text] [Related]

  • 10. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
    Picard LS, Lindsay S, Strawn JR, Kaneria RM, Patel NC, Keck PE.
    Pharmacotherapy; 2008 Apr; 28(4):530-5. PubMed ID: 18363536
    [Abstract] [Full Text] [Related]

  • 11. A comparison of diagnostic criteria for neuroleptic malignant syndrome.
    Gurrera RJ, Chang SS, Romero JA.
    J Clin Psychiatry; 1992 Feb; 53(2):56-62. PubMed ID: 1347292
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical study of neuroleptic malignant syndrome in demented patients--examination of our case and reported cases].
    Kimura T, Yoshida H.
    No To Shinkei; 1994 Sep; 46(9):859-62. PubMed ID: 7999444
    [Abstract] [Full Text] [Related]

  • 14. Frequency of neuroleptic malignant syndrome in a large psychiatric hospital in Moscow.
    Spivak B, Maline DI, Kozyrev VN, Mester R, Neduva SA, Ravilov RS, Weizman A.
    Eur Psychiatry; 2000 Aug; 15(5):330-3. PubMed ID: 10954877
    [Abstract] [Full Text] [Related]

  • 15. Neuroleptic toxicity syndromes: a clinical spectrum.
    Reilly JJ, Crowe SF, Lloyd JH.
    Aust N Z J Psychiatry; 1991 Dec; 25(4):499-505. PubMed ID: 1686547
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia.
    Srivastava A, Borkar HA, Chandak S.
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):119-21. PubMed ID: 19067992
    [Abstract] [Full Text] [Related]

  • 18. NMS and lethal catatonia.
    Weller M.
    J Clin Psychiatry; 1992 Aug; 53(8):294-5. PubMed ID: 1500409
    [No Abstract] [Full Text] [Related]

  • 19. [Neuroleptic malignant syndrome. Case reports].
    Berardi D, Troia M, Veronesi L, Ferrari G.
    Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
    [Abstract] [Full Text] [Related]

  • 20. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
    Musselman ME, Browning LA, Parker D, Saely S.
    Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.